Albert David (Small Cap) Share Target 2026, 2027 To 2035
|
Albert David Limited |
|||
|
Price: ₹721.35 (-0.59%) | ||
| 52 Week Low: ₹579.90 52 Week High: ₹957.50 |
|||
| Market Capital: 410.74 Crore (Small-cap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Share Price HistoryALBERTDAVD FinancialsTomorrow TargetYearly TargetsDividend HistoryNo BonusNo Split
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Albert David Share Price Target For 2026
- 1.1.1: Albert David Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Albert David Share Price Target For 2027
- 1.2.1: Albert David Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Albert David Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Albert David Brief Company Overview
- 4: Albert David Financial Performance
- 4.0.1: Is Albert David A Good Buy For Long Term?
Albert David, a Small Cap company in the Drug Manufacturers - Specialty & Generic Industry has delivered 49.4% returns in 5-year with 19.7% profit margin.
To predict the Albert David's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Albert David Share Price Target For 2026
The line chart displays the monthly closing prices of Albert David with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Albert David shares in 2026, see the table below.
Albert David Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 768.88 (+6.58%) | Trend: Supertrend Resistance |
| 2026 Target 2 | 746.65 (+3.5%) | Trend: SMA200 |
| 2026 Target 1 | 728.16 (+0.94%) | Volatility: BB Upper |
| Current Price | 721.35 | Albert David's share price as of 15 Jun 2026 |
| Stop Loss 1 | 717.60 (-0.52%) | Trend: SMA50 |
| Stop Loss 2 | 710.51 (-1.51%) | Trend: EMA9 |
| Stop Loss 3 | 691.65 (-4.12%) | Volatility: BB Lower |
Short-Term Technical Outlook
Current Technical Position: Albert David is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 50-day moving average at ₹717.6 serves as the nearest technical reference point.
Historical Returns: 3-month: +7.01% | 6-month: -4.08% | 1-year: -15.89%
Albert David Share Price Target For 2027
The line chart displays the monthly closing prices of Albert David with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Albert David shares in 2027, see the table below.
Albert David Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 768.88 (+6.58%) | Trend: Supertrend Resistance |
| 2027 Target 2 | 746.65 (+3.5%) | Trend: SMA200 |
| 2027 Target 1 | 728.16 (+0.94%) | Volatility: BB Upper |
| Current Price | 721.35 | Albert David's share price as of 15 Jun 2026 |
| Stop Loss 1 | 717.60 (-0.52%) | Trend: SMA50 |
| Stop Loss 2 | 710.51 (-1.51%) | Trend: EMA9 |
| Stop Loss 3 | 691.65 (-4.12%) | Volatility: BB Lower |
Long-Term Technical Outlook
52-Week Range Analysis: Albert David is currently trading at 37.5% of its 52-week range (₹579.9 - ₹957.5).
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -15.89% | 3-year: +17.53% | 5-year: +49.44%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Albert David Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹721.35 | ||
| 2026 | ₹819.89 | +13.660497677965% | ₹832.19 |
| 2027 | ₹884.81 | +7.9181353596214% | ₹898.08 |
| 2028 | ₹973.72 | +10.048484985477% | ₹988.33 |
| 2029 | ₹1,069.55 | +9.8416382532966% | ₹1,085.59 |
| 2030 | ₹1,194.70 | +11.701182740405% | ₹1,212.62 |
| 2031 | ₹1,374.83 | +15.077425295053% | ₹1,395.45 |
| 2032 | ₹1,555.26 | +13.123804397635% | ₹1,578.59 |
| 2033 | ₹1,689.50 | +8.6313542430205% | ₹1,714.84 |
| 2034 | ₹1,819.71 | +7.7070139094407% | ₹1,847.01 |
| 2035 | ₹1,935.07 | +6.3394716740579% | ₹1,964.10 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Albert David Brief Company Overview
Albert David Limited OverviewAlbert David Limited is an esteemed pharmaceutical player in India, manufacturing and trading a diverse range of formulations, solutions, and medical disposables. Established in 1938, the company has a long-standing presence in the industry....
Headquartered in Kolkata, it operates across India and exports its products globally, notably to Latin America, Southeast Asia, and Africa. Albert David Limited's commitment to quality and innovation is reflected in its extensive product portfolio, encompassing parenterals, oral/enteral formulations, topical agents, and vision care products. Additionally, the company produces bulk drugs, disposable syringes, and needles, catering to diverse healthcare needs.Albert David Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 762.19 Crore | Market valuation of Albert David's shares. |
| Revenue (TTM) | 359.87 Crore | Total revenue generated by Albert David over the past twelve months. |
| Net Income (TTM) | +70.77 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -1.02% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 19.66% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-2.8% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-19.8% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
0.86 | Company's total debt divided by total shareholder equity. |
| Total Debt | 3.32 Crore | Sum of Albert David's current & long-term financial obligations. |
| Total Cash | 285.22 Crore | Total amount of liquid funds available to Albert David. |
| Beta | 0.4 | Beta is less than 1 indicating that the Albert David's price is less volatile than the market. |
Is Albert David A Good Buy For Long Term?
Albert David, a small-cap stock with a market capitalization of ₹762.19 crore, shows strong long-term growth potential. While Q1 2024-25 earnings decreased 19.8% year-over-year and revenue slightly dipped 2.8% quarter-over-quarter, its robust profit margin of 19.66% and substantial cash balance of ₹285.22 crore are positive indicators. Past performance, with 5-year returns exceeding 210.86%, is impressive. However, the recent 3-month return of -2.91% warrants caution. Considering the overall picture, it's a good buy for long-term investors with a moderate risk tolerance.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
